Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

What you will find here:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest market stories

Prediction: Alphabet's Profit Growth Carries It to $5 Trillion Before 2028

2026-10-05 07:37 • The Motley Fool Positive Axe Cap view: Selective

Alphabet is predicted to reach a $5 trillion market valuation before the end of 2027, driven by strong profit growth. The company's operating income surged 30% year-over-year in Q2 2026, with Google Cloud contributing significantly through 82% revenue growth and improved margins. However, rising depreciation expenses pose a risk to the forecast, as capital spending is expected to increase substantially in 2027.

Axe note: Alphabet’s rapid profit growth points to a $5 trillion market cap by 2027, raising questions for South African investors.

Nebius Has $40 Billion of Customer Commitments. Most of It Comes From 2 Customers.

2026-10-05 07:12 • The Motley Fool Negative Axe Cap view: Selective

Nebius, an AI cloud company, has $40 billion in customer commitments, with approximately $32 billion in firm contracts coming from just two customers: Microsoft ($17.4-19.4 billion) and Meta ($15 billion total). While the signed contracts provide revenue security with upfront payments and limited cancellation clauses, the analyst expresses concern that the stock valuation assumes many more major contracts beyond these two customers, and recommends waiting for evidence of a broader customer base before investing at current prices near $243 per share.

Axe note: Nebius’ $40 billion customer commitments are mostly tied to two hyperscalers, raising valuation and diversification concerns.

Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBB

2026-10-05 05:04 • The Motley Fool Positive Axe Cap view: Selective

The article compares two healthcare ETFs: Vanguard Health Care ETF (VHT) offers broad sector exposure with a low 0.09% expense ratio and 1.4% dividend yield, while iShares Biotechnology ETF (IBB) focuses on biotech with higher growth potential (49.8% 1-year return) but greater volatility and a 39.8% maximum drawdown. VHT is recommended for conservative investors seeking stability, while IBB suits high-risk growth investors.

Axe note: Comparing Vanguard's broad healthcare exposure to iShares' biotech-focused volatility.

See all market stories →

What we follow

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

JSE and rand